January 13, 2020
23andMe is teaming up with Spanish drugmaker Almirall to develop an antibody that treats certain inflammatory diseases using customer data.
January 6, 2020
At the dawn of a new year, INN offers a preview of potential developments in the pharmaceutical market throughout 2020.
October 2, 2019
The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
September 10, 2019
VBI Vaccines (NASDAQ:VBI) has announced a collaboration with GlaxoSmithKline (NYSE:GSK) to evaluate VBI’s VBI-1901 with GSK’s AS01 adjuvant system. As...
August 29, 2019
The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
August 28, 2019
We break down the top pharma companies by revenue in 2018, according to information from research firm GlobalData.
August 15, 2019
Drug sales are expected to top US$1 trillion by 2024, even though a number of patents are set to expire...